Decreased expression of Nrf2 related genes and stemness markers in Nrf2 knocked down resistant Huh7 cells treated with siRNA. by Luping Gao (4269754)

A coarse-grained sensitivity analysis of the effect of drug-induced resistance on treatment outcome. by Erin Angelini (13149930)

In BC tissue samples and BC cell lines, the expression of let-7b-5p decreased while the expression of AURKB increased. by Murat Kaya (578380)

Tumors from vehicle-treated mice were collected at the end of study, homogenized, and assessed for expression of FGFR1, vimentin, and β-actin. by Angela Abdollahi (15166230)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Gene set enrichment analysis (GSEA) suggests increased proliferation, decreased keratinocyte differentiation and decreased E-cadherin signaling in both the type 1 EBV-infected and... by Deo R. Singh (4784112)

Gene set enrichment analysis (GSEA) suggests increased proliferation, decreased keratinocyte differentiation and decreased E-cadherin signaling in both the type 1 EBV-infected and... by Deo R. Singh (4784112)

Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insights by Daniel Nettersheim (2866097)

“…</p><p><br></p> <p>Results:</p><p>We present seven different epigenetic inhibitors efficiently decreasing cell viability in GCT cell lines including cisplatin-resistant subclones at low concentrations by targeting epigenetic modifiers and interactors, like histone deacetylases (Quisinostat), histone demethylases (JIB-04), histone methyltransferases (Chaetocin), epigenetic readers (MZ-1, LP99) and polycomb-repressive complexes (PRT4165, GSK343). …”

Estimated resistance for nine wildlife species in New England, USA. by Schuyler B. Pearman-Gillman (8938661)

Distributions of singscore-based EMT scores for TCGA samples across 32 tumor types using signature genes described in Mak MP, et al. (Clin Cancer Res. 2016;22: 609–620). by Angela Abdollahi (15166230)

Subjects:

PCR primers of the tetracycline resistance genes and denitrification functional genes. by Yan Shu (441370)

OsNF-YAs negatively modulate rice resistance to RSV and SRBSDV. by Xiaoxiang Tan (12542842)

RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance by Shuyun Rao (449181)

Subjects:

Changes in data-based resistance and data-based aggressiveness during therapy. by Kanyarat Jitmana (18693060)

Subjects:

<i>OsNF-YAs</i> RNAi mutants are more resistant to viruses. by Xiaoxiang Tan (12542842)